Cellulose Acetate Phthalate and Antiretroviral Nanoparticle Fabrications for HIV Pre-Exposure Prophylaxis

Topical Tenofovir Disoproxil Fumarate Nanoparticles Prevent HIV-1 Vaginal Transmission in a Humanized Mouse Model

(2016) Christopher J. Destache et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

An Enhanced Emtricitabine-Loaded Long-Acting Nanoformulation for Prevention or Treatment of HIV Infection

(2016) Subhra Mandal et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Thermosensitive Gel Containing Cellulose Acetate Phthalate-Efavirenz Combination Nanoparticles for Prevention of HIV-1 Infection

(2015) Abhijit A. Date et al.   Journal of Biomedical Nanotechnology

Confocal fluorescence microscopy: An ultra-sensitive tool used to evaluate intracellular antiretroviral nano-drug delivery in HeLa cells

(2015) Subhra Mandal et al.   AIP Advances

Simulated Biological Fluids with Possible Application in Dissolution Testing

(2015) Margareth R. C. Marques et al.   DISSOLUTION TECHNOLOGIES

Dolutegravir: A Next-Generation Integrase Inhibitor for Treatment of HIV Infection

(2014) D. A. Osterholzer et al.   CLINICAL INFECTIOUS DISEASES

Dolutegravir: A Review of Its Use in the Management of HIV-1 Infection in Adolescents and Adults

(2014) Paul L. McCormack   DRUGS

Preventing HIV infection: Pre-exposure and postexposure prophylaxis

(2014) Susanne Doblecki-Lewis et al.   IUBMB LIFE

Comparative replication capacity of raltegravir-resistant strains and antiviral activity of the new-generation integrase inhibitor dolutegravir in human primary macrophages and lymphocytes

(2014) M. Pollicita et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

(2014) A. Castagna et al.   JOURNAL OF INFECTIOUS DISEASES

Dolutegravir: clinical efficacy and role in HIV therapy

(2014) Alessandra Fantauzzi et al.   Therapeutic Advances in Chronic Disease

Assessment of topical microbicides to prevent HIV-1 transmission: Concepts, testing, lessons learned

(2013) David R. Friend et al.   ANTIVIRAL RESEARCH

Electrospun fibers for vaginal anti-HIV drug delivery

(2013) Anna K. Blakney et al.   ANTIVIRAL RESEARCH

Preventing HIV Infection in Women

(2013) Adaora A. Adimora et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

The Activity of the Integrase Inhibitor Dolutegravir Against HIV-1 Variants Isolated From Raltegravir-Treated Adults

(2012) Mark R. Underwood et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Reformulated tenofovir gel for use as a dual compartment microbicide

(2012) C. S. Dezzutti et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Molecular Dynamics Approaches Estimate the Binding Energy of HIV-1 Integrase Inhibitors and Correlate withIn VitroActivity

(2011) Barry C. Johnson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Dolutegravir (S/GSK1349572) Exhibits Significantly Slower Dissociation than Raltegravir and Elvitegravir from Wild-Type and Integrase Inhibitor-Resistant HIV-1 Integrase-DNA Complexes

(2011) Kendra E. Hightower et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The rise and fall of polyanionic inhibitors of the human immunodeficiency virus type 1

(2011) Vanessa Pirrone et al.   ANTIVIRAL RESEARCH

Electrospun cellulose acetate phthalate fibers for semen induced anti-HIV vaginal drug delivery

(2011) Chaobo Huang et al.   BIOMATERIALS

In VitroAntiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor

(2010) Masanori Kobayashi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Preventing mucosal HIV transmission with topical microbicides: Challenges and opportunities

(2010) Florian Hladik et al.   ANTIVIRAL RESEARCH

Unacceptable side-effects associated with a hyperosmolar vaginal microbicide in a phase 1 trial

(2010) C J Lacey et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Antiretroviral release from poly(DL-lactide-co-glycolide) nanoparticles in mice

(2010) C. J. Destache et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Emerging nanotechnology approaches for HIV/AIDS treatment and prevention

(2010) Tewodros Mamo et al.   Nanomedicine

Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

(2010) Q. Abdool Karim et al.   SCIENCE

Microbicides and HIV prevention: lessons from the past, looking to the future

(2009) Georgina C Morris et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors

(2009) Erik Serrao et al.   Retrovirology